Acme Lab Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 458.13%
(FY 2020)
- Ebitda 103.11%
(FY 2020)
- Net Worth 21.97%
(FY 2020)
- Total Assets 1.70%
(FY 2020)
About Acme Lab Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Kamal, Soma Rai, and Shivani Rai serve as directors at the Company.
- CIN/LLPIN
U33110RJ2011PTC033817
- Company No.
033817
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acme Lab Instruments Private Limited offer?
Acme Lab Instruments Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Blood Bank Equipments, Weighing Scales & Measuring Tapes, Food Weighing Machine, Pathology Lab Equipments, Autoclaves, Sterilizers & Incubators, Lab Incubator, Laboratory & Lab Equipment, Laboratory Shakers, Laboratory Bath.
Who are the key members and board of directors at Acme Lab Instruments?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Kamal  | Director | 10-Jan-2011 | Current |
| Soma Rai | Director | 20-Oct-2011 | Current |
| Shivani Rai | Director | 15-Feb-2020 | Current |
Financial Performance of Acme Lab Instruments.
Acme Lab Instruments Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 458.13% increase in profit. The company's net worth Soared by an impressive increase of 21.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acme Lab Instruments?
In 2018, Acme Lab Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivani Medical Equipments Private LimitedActive 4 years 21 daysPraveen Kamal, Soma Rai and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Acme Lab Instruments?
Unlock and access historical data on people associated with Acme Lab Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acme Lab Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Lab Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
